189 related articles for article (PubMed ID: 31452174)
1. Inhibition of the Invasion of Human Glioblastoma U87 Cell Line by Ruxolitinib: A Molecular Player of miR-17 and miR-20a Regulating JAK/STAT Pathway.
Delen E; Doganlar O; Doganlar ZB; Delen O
Turk Neurosurg; 2020; 30(2):182-189. PubMed ID: 31452174
[TBL] [Abstract][Full Text] [Related]
2. Ruxolitinib attenuates intimal hyperplasia via inhibiting JAK2/STAT3 signaling pathway activation induced by PDGF-BB in vascular smooth muscle cells.
Song HT; Cui Y; Zhang LL; Cao G; Li L; Li G; Jia XJ
Microvasc Res; 2020 Nov; 132():104060. PubMed ID: 32818511
[TBL] [Abstract][Full Text] [Related]
3. Effect and mechanism of miR-135a-5p/CXCL12/JAK-STAT axis on inflammatory response after myocardial infarction.
Guo XY; Liu QL; Liu W; Cheng JX; Li ZJ
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12912-12928. PubMed ID: 33378042
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of JAK2/STAT3/SOCS3 signaling attenuates atherosclerosis in rabbit.
Yang X; Jia J; Yu Z; Duanmu Z; He H; Chen S; Qu C
BMC Cardiovasc Disord; 2020 Mar; 20(1):133. PubMed ID: 32169038
[TBL] [Abstract][Full Text] [Related]
5. The Dose Dependent Effects of Ruxolitinib on the Invasion and Tumorigenesis in Gliomas Cells via Inhibition of Interferon Gamma-Depended JAK/STAT Signaling Pathway.
Delen E; Doğanlar O
J Korean Neurosurg Soc; 2020 Jul; 63(4):444-454. PubMed ID: 32492985
[TBL] [Abstract][Full Text] [Related]
6. Silencing microRNA-221/222 cluster suppresses glioblastoma angiogenesis by suppressor of cytokine signaling-3-dependent JAK/STAT pathway.
Xu CH; Liu Y; Xiao LM; Chen LK; Zheng SY; Zeng EM; Li DH; Li YP
J Cell Physiol; 2019 Dec; 234(12):22272-22284. PubMed ID: 31106423
[TBL] [Abstract][Full Text] [Related]
7. MiR-203 regulates JAK-STAT pathway in affecting pancreatic cancer cells proliferation and apoptosis by targeting SOCS3.
Lin XM; Chen H; Zhan XL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6906-6913. PubMed ID: 31486490
[TBL] [Abstract][Full Text] [Related]
8. miR-34b Alleviates High Glucose-Induced Inflammation and Apoptosis in Human HK-2 Cells via IL-6R/JAK2/STAT3 Signaling Pathway.
Lv N; Li C; Liu X; Qi C; Wang Z
Med Sci Monit; 2019 Oct; 25():8142-8151. PubMed ID: 31665127
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of microRNA-133a and downregulation of connective tissue growth factor suppress cell proliferation, migration, and invasion in human glioma through the JAK/STAT signaling pathway.
Zhang P; Chen FZ; Jia QB; Hu DF
IUBMB Life; 2019 Dec; 71(12):1857-1875. PubMed ID: 31381269
[TBL] [Abstract][Full Text] [Related]
10. Suppression of microRNA-135b-5p protects against myocardial ischemia/reperfusion injury by activating JAK2/STAT3 signaling pathway in mice during sevoflurane anesthesia.
Xie XJ; Fan DM; Xi K; Chen YW; Qi PW; Li QH; Fang L; Ma LG
Biosci Rep; 2017 Jun; 37(3):. PubMed ID: 28522550
[TBL] [Abstract][Full Text] [Related]
11. Anti-myeloma effects of ruxolitinib combined with bortezomib and lenalidomide: A rationale for JAK/STAT pathway inhibition in myeloma patients.
de Oliveira MB; Fook-Alves VL; Eugenio AIP; Fernando RC; Sanson LFG; de Carvalho MF; Braga WMT; Davies FE; Colleoni GWB
Cancer Lett; 2017 Sep; 403():206-215. PubMed ID: 28645562
[TBL] [Abstract][Full Text] [Related]
12. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
Li XD; Li XM; Gu JW; Sun XC
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427
[TBL] [Abstract][Full Text] [Related]
13. microRNA-146a Promotes Growth of Acute Leukemia Cells by Downregulating Ciliary Neurotrophic Factor Receptor and Activating JAK2/STAT3 Signaling.
Wang L; Zhang H; Lei D
Yonsei Med J; 2019 Oct; 60(10):924-934. PubMed ID: 31538427
[TBL] [Abstract][Full Text] [Related]
14. Tumoricidal effects of the JAK inhibitor Ruxolitinib (INC424) on hepatocellular carcinoma in vitro.
Wilson GS; Tian A; Hebbard L; Duan W; George J; Li X; Qiao L
Cancer Lett; 2013 Dec; 341(2):224-30. PubMed ID: 23941832
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of miR-216a exerts neuroprotective effects against ischemic injury through negatively regulating JAK2/STAT3-involved apoptosis and inflammatory pathways.
Tian YS; Zhong D; Liu QQ; Zhao XL; Sun HX; Jin J; Wang HN; Li GZ
J Neurosurg; 2018 Mar; 130(3):977-988. PubMed ID: 29521586
[TBL] [Abstract][Full Text] [Related]
16. Induction of autophagy biomarker BNIP3 requires a JAK2/STAT3 and MT1-MMP signaling interplay in Concanavalin-A-activated U87 glioblastoma cells.
Pratt J; Annabi B
Cell Signal; 2014 May; 26(5):917-24. PubMed ID: 24462646
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC.
Hu Y; Hong Y; Xu Y; Liu P; Guo DH; Chen Y
Apoptosis; 2014 Nov; 19(11):1627-36. PubMed ID: 25213670
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-363 inhibits angiogenesis, proliferation, invasion, and migration of renal cell carcinoma via inactivation of the Janus tyrosine kinases 2-signal transducers and activators of transcription 3 axis by suppressing growth hormone receptor gene.
Zhu J; Zhu DQ; Zhang Y; Liu QM; Wang PC; Li HZ; Ma X; Zhang X
J Cell Physiol; 2019 Mar; 234(3):2581-2592. PubMed ID: 30229899
[TBL] [Abstract][Full Text] [Related]
19. The JAK1/JAK2- inhibitor ruxolitinib inhibits mast cell degranulation and cytokine release.
Hermans MAW; Schrijver B; van Holten-Neelen CCPA; Gerth van Wijk R; van Hagen PM; van Daele PLA; Dik WA
Clin Exp Allergy; 2018 Nov; 48(11):1412-1420. PubMed ID: 29939445
[TBL] [Abstract][Full Text] [Related]
20. The role of melatonin in angio-miR-associated inhibition of tumorigenesis and invasion in human glioblastoma tumour spheroids.
Doğanlar O; Doğanlar ZB; Delen E; Doğan A
Tissue Cell; 2021 Dec; 73():101617. PubMed ID: 34418770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]